Announcements Trials
Browse Landscape

Phase

Phase 4 1

Status

Active not recruiting 1

Sponsor Class

NIH 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Hepatitis C 2Carcinoma, Hepatocellular 2Recurrence 1Hepatitis C, Chronic 1Fibrosis 1Diabetes Mellitus 1Cardiovascular Diseases 1

Interventions

Surveys and Questionnaires 2Biopsy 2tislelizumab 1sofosbuvir-velpatasvir drug combination 1epalrestat 1donafenib 1Urine Specimen Collection 1Specimen Handling 1Secretin 1Risk Assessment 1Phlebotomy 1Pancreaticoduodenectomy 1Pancreas, Artificial 1Methods 1Magnetic Resonance Spectroscopy 1Lysine Acetyltransferase 5 1Liquid Biopsy 1Interviews as Topic 1Gastric Bypass 1Gastrectomy 1Exercise 1Endoscopic Mucosal Resection 1Clinical Laboratory Techniques 1Blood Specimen Collection 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Diabetes Mellitus × sofosbuvir-velpatasvir drug combination × Gastrointestinal × Clear all
NCT03520660 2026-06-03

People With CHC Who Achieved a Sustained Virological Response Following Therapy With Direct Acting Antiviral Agents

National Institutes of Health Clinical Center (CC)

Phase 4 Active not recruiting
121 enrolled
Gastrointestinal

Cardiovascular Diseases, Diabetes Mellitus, Fibrosis, Hepatitis C, Carcinoma, Hepatocellular, Hepatitis C, Chronic

Data powered by HemOnc (CC BY 4.0) Colophon âš¡